rs375716806
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000674643.1(GARS1):n.*1681T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,611,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.00017   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.00014   (  0   hom.  ) 
Consequence
 GARS1
ENST00000674643.1 non_coding_transcript_exon
ENST00000674643.1 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.00400  
Publications
0 publications found 
Genes affected
 GARS1  (HGNC:4162):  (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015] 
GARS1 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8). 
BP6
Variant 7-30632219-T-G is Benign according to our data. Variant chr7-30632219-T-G is described in ClinVar as Likely_benign. ClinVar VariationId is 258535.Status of the report is criteria_provided_single_submitter, 1 stars. 
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000171 (26/152362) while in subpopulation NFE AF = 0.000309 (21/68032). AF 95% confidence interval is 0.000207. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High AC in GnomAd4 at 26 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000674643.1 | n.*1681T>G | non_coding_transcript_exon_variant | Exon 16 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674643.1 | n.*1681T>G | 3_prime_UTR_variant | Exon 16 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000389266.8 | c.1904-28T>G | intron_variant | Intron 15 of 16 | 1 | NM_002047.4 | ENSP00000373918.3 | |||
| GARS1 | ENST00000675651.1 | c.1922-28T>G | intron_variant | Intron 15 of 16 | ENSP00000502513.1 | |||||
| GARS1 | ENST00000675810.1 | c.1802-28T>G | intron_variant | Intron 14 of 15 | ENSP00000502743.1 | |||||
| GARS1 | ENST00000675693.1 | c.1736-28T>G | intron_variant | Intron 16 of 17 | ENSP00000502174.1 | |||||
| GARS1 | ENST00000675051.1 | c.1703-28T>G | intron_variant | Intron 15 of 16 | ENSP00000502296.1 | |||||
| GARS1 | ENST00000674815.1 | c.1535-28T>G | intron_variant | Intron 15 of 16 | ENSP00000502799.1 | |||||
| GARS1 | ENST00000674851.1 | c.1535-28T>G | intron_variant | Intron 16 of 17 | ENSP00000502451.1 | |||||
| GARS1 | ENST00000444666.6 | n.*325-28T>G | intron_variant | Intron 16 of 17 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*1618-28T>G | intron_variant | Intron 16 of 17 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674737.1 | n.*1242-28T>G | intron_variant | Intron 16 of 17 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.*177-28T>G | intron_variant | Intron 14 of 15 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1774-28T>G | intron_variant | Intron 16 of 17 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.*83-28T>G | intron_variant | Intron 13 of 14 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1846-28T>G | intron_variant | Intron 17 of 18 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*849-28T>G | intron_variant | Intron 15 of 16 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*1355-28T>G | intron_variant | Intron 15 of 16 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*1193-28T>G | intron_variant | Intron 16 of 17 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*1336-28T>G | intron_variant | Intron 15 of 16 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.1810-28T>G | intron_variant | Intron 14 of 15 | ENSP00000502681.1 | 
Frequencies
GnomAD3 genomes  0.000171  AC: 26AN: 152244Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
26
AN: 
152244
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000158  AC: 39AN: 246466 AF XY:  0.000209   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
39
AN: 
246466
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000143  AC: 209AN: 1458826Hom.:  0  Cov.: 30 AF XY:  0.000142  AC XY: 103AN XY: 725932 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
209
AN: 
1458826
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
103
AN XY: 
725932
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
33386
American (AMR) 
 AF: 
AC: 
7
AN: 
44632
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26088
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39672
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
85998
European-Finnish (FIN) 
 AF: 
AC: 
6
AN: 
53248
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5758
European-Non Finnish (NFE) 
 AF: 
AC: 
189
AN: 
1109754
Other (OTH) 
 AF: 
AC: 
5
AN: 
60290
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 12 
 25 
 37 
 50 
 62 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000171  AC: 26AN: 152362Hom.:  0  Cov.: 32 AF XY:  0.000148  AC XY: 11AN XY: 74514 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
26
AN: 
152362
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
11
AN XY: 
74514
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
41590
American (AMR) 
 AF: 
AC: 
0
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5188
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
21
AN: 
68032
Other (OTH) 
 AF: 
AC: 
0
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 2 
 3 
 5 
 6 
 8 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.